TY - JOUR
T1 - Laser Uses in Noncoronary Arterial Disease
AU - Jayet, Jérémie
AU - Coscas, Raphaël
AU - Heim, Frédéric
AU - Goeau-Brissonniere, Olivier
AU - Javerliat, Isabelle
AU - Chakfe, Nabil
AU - Coggia, Marc
N1 - Funding Information:
Funding: The authors thank the “Société Française de chirurgie vasculaire et endovasculaire” (SCVE), the “Association chirurgicale pour le développement et l'Amélioration des techniques de Dépistage et de Traitement des maladies Cardiovasculaires” (ADETEC), and the “Association pour la Recherche et la Formation Chirurgicale en Ile de France” (ARFCIDF) for providing funding for this study. Funding: The authors thank the “Société Française de chirurgie vasculaire et endovasculaire” ( SCVE), the “Association chirurgicale pour le développement et l'Amélioration des techniques de Dépistage et de Traitement des maladies Cardiovasculaires” ( ADETEC), and the “Association pour la Recherche et la Formation Chirurgicale en Ile de France” ( ARFCIDF) for providing funding for this study.
Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2019/5
Y1 - 2019/5
N2 - Background: In the past decade, excimer laser angioplasty (ELA) has emerged in the field of peripheral artery disease (PAD). Laser indications now extend to off-label uses, such as in situ fenestration of aortic endograft. The aim of this study was to review the different therapeutics applications of lasers in arterial disease treatment. Methods: We reviewed the English-language literature using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. We selected 106 relevant papers. We excluded unrelated papers (n = 67), letters and commentaries (n = 6), and review articles (n = 7), leaving 26 articles to form the basis of this review. Results: A total of 18 articles were included in the analysis of ELA applications in PAD. Nine articles were related to atherosclerotic plaques. With a mean follow-up of 15 ± 7 months, primary patency was 65% ± 20%. The mean distal embolism rate during the procedure was 5%. Eight more articles focused on in-stent restenosis. The mean technical success was 98%, and the rate of distal embolism during the procedure was 9%. With a mean follow-up of 10 ± 4 months, primary patency was 68% ± 18%. Eight articles described “off-label” excimer laser indications in endovascular therapy, including 5 papers regarding in situ fenestrations for complex aortic aneurysms. Conclusion: Laser atherectomy and laser-assisted techniques are an important part of a vascular surgeon and interventionalist's armamentarium.
AB - Background: In the past decade, excimer laser angioplasty (ELA) has emerged in the field of peripheral artery disease (PAD). Laser indications now extend to off-label uses, such as in situ fenestration of aortic endograft. The aim of this study was to review the different therapeutics applications of lasers in arterial disease treatment. Methods: We reviewed the English-language literature using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. We selected 106 relevant papers. We excluded unrelated papers (n = 67), letters and commentaries (n = 6), and review articles (n = 7), leaving 26 articles to form the basis of this review. Results: A total of 18 articles were included in the analysis of ELA applications in PAD. Nine articles were related to atherosclerotic plaques. With a mean follow-up of 15 ± 7 months, primary patency was 65% ± 20%. The mean distal embolism rate during the procedure was 5%. Eight more articles focused on in-stent restenosis. The mean technical success was 98%, and the rate of distal embolism during the procedure was 9%. With a mean follow-up of 10 ± 4 months, primary patency was 68% ± 18%. Eight articles described “off-label” excimer laser indications in endovascular therapy, including 5 papers regarding in situ fenestrations for complex aortic aneurysms. Conclusion: Laser atherectomy and laser-assisted techniques are an important part of a vascular surgeon and interventionalist's armamentarium.
UR - http://www.scopus.com/inward/record.url?scp=85052988477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052988477&partnerID=8YFLogxK
U2 - 10.1016/j.avsg.2018.06.010
DO - 10.1016/j.avsg.2018.06.010
M3 - Review article
C2 - 30118856
AN - SCOPUS:85052988477
VL - 57
SP - 229
EP - 237
JO - Annals of Vascular Surgery
JF - Annals of Vascular Surgery
SN - 0890-5096
ER -